Skip to main content
. 2022 Dec 29;13(1):100. doi: 10.3390/life13010100

Figure 1.

Figure 1

Animal study and the effect of ALS-L1023 on body weight, food intake, liver, and biochemical markers in the choline-deficient high-fat diet (CDHFD)-induced non-alcoholic fatty liver disease model. (A) Schematic of the animal study. (B) Body weight and food intake. (C) Liver images of the CDHF, obeticholic acid (OCA), ALS-L1023 low dose, and ALS-L1023 high dose groups. (D) Biochemical marker analysis. Data are presented as mean ± standard deviation and were analyzed by Mann-Whitney U test. *** p < 0.001, **** p < 0.0001 compared to the CDHF group.